Germany’s Merck boosts life sciences business with $11 billion Bio-Techne deal – CNBC
German drugmaker Merck ​KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest deal in over a decade.Read More
German drugmaker Merck ​KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest deal in over a decade.Read More
by Newsbot · Published June 25, 2026
by Newsbot · Published June 25, 2026
by Newsbot · Published June 25, 2026
by Newsbot · Published June 25, 2026
by Newsbot · Published June 25, 2026
by Newsbot · Published June 25, 2026
by Newsbot · Published June 25, 2026
by Newsbot · Published June 25, 2026
by Newsbot · Published June 25, 2026
by Newsbot · Published June 24, 2026
